Table 4.
Mean ingredient plasma levels (standard deviation)
| Mean plasma levels | Placebo group | Test group 1 | Test group 2 |
|---|---|---|---|
| Vitamin C (μM) | |||
| T1 | 55.07 (15.66) | 59.50 (16.8) | 56.85 (17.8) |
| T9 | 52.80 (15.05) | 74.64 (19.54)*† | 72.37 (13.93)*† |
| T15 | 55.00 (13.22) | 72.30 (17.06)*† | 72.46 (14.56)*† |
| Vitamin E (μM) | |||
| T1 | 34.44 (7.45) | 34.60 (9) | 38.50 (10)†‡ |
| T9 | 34.85 (7.28) | 50.10 (14)*† | 46.90 (13)*† |
| T15 | 36.30 (7.58) | 50.90 (13)*† | 47.20 (11)*† |
| Lycopene (μg L−1) | |||
| T1 | 114.94 (65.76) | 108.71 (77) | 124.00 (75) |
| T9 | 120.50 (74.09) | 234.70 (104)*†‡ | 179.20 (70)*†‡ |
| T15 | 100.87 (61.00) | 254.40 (103)*†‡ | 201.4 (75)*†‡ |
| Plasma EPA (μg mL−1) | |||
| T1 | 43.37 (26.11) | 42.91 (28.59) | 44.40 (41.2) |
| T15 | 42.98 (21.36) | 67.32 (26.45)*† | 71.09 (28.28)*† |
| Plasma DHA (μg mL−1) | |||
| T1 | 80.20 (26.86) | 76.25 (29.37) | 80.36 (23.69) |
| T15 | 82.69 (25.10) | 97.54 (31.18)*† | 103.56 (33.36)*† |
*
Significant difference from baseline (T1): P < 0.05.
†
Significant difference from placebo (within time point): P < 0.05.
‡
Significant difference from other active treatment (within time point): P < 0.05.